Clinicopathological Evaluation of the Revised European-American Classification of Lymphoid Neoplasms (REAL) in Japan
Author:
Affiliation:
1. First Department of Pathology, Chiba University School of Medicine, 1-8-1, Inohana, Chuou-ku, Chiba city, 260-8670, Japan
2. Department of Radiology, Chiba University School of Medicine, 1-8-1, Inohana, Chuou-ku, Chiba city, 260-8670, Japan
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
https://www.tandfonline.com/doi/pdf/10.3109/10428199909083390
Reference19 articles.
1. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
2. National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usage
3. Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the Working Formulation
4. A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Non-biased and complete case registration of lymphoid leukemia and lymphoma for five years: a first representative index of Japan from an epidemiologically stable Miyagi Prefecture;Leukemia & Lymphoma;2016-05-17
2. Autologous Stem Cell Transplantation as the First-Line Treatment for Peripheral T Cell Lymphoma: Results of a Comprehensive Meta-Analysis;Acta Haematologica;2013-10-19
3. Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas;Expert Opinion on Biological Therapy;2010-11-13
4. Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification;American Journal of Hematology;2010-08-30
5. Aggressive Non‐Hodgkin's Lymphomas;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3